BURNS Christopher John,BURNS Christopher John,KLING Marcel Robert,KLING Marcel Robert
申请号：
SI200332471
公开号：
SI1569907T1
申请日:
2003.12.15
申请国别(地区):
SI
年份:
2016
代理人:
摘要：
A compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating tyrosine kinase-associated disease states in a subject using a compound of formula (I) is also described.
